| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |